STAAR Surgical Depreciation And Amortization Over Time
| STAA Stock | USD 17.57 0.11 0.63% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out STAAR Surgical Performance and STAAR Surgical Correlation. STAAR |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share (0.41) | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Depreciation And Amortization Analysis
Compare STAAR Surgical and related stocks such as ResMed Inc, West Pharmaceutical, and ICU Medical Depreciation And Amortization Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RMD | 200 K | 14 M | 10.1 M | 9.7 M | 73.1 M | 86.8 M | 112.2 M | 120 M | 264.2 M | 180.2 M | 191.5 M | 193.8 M | 196.5 M | 216.2 M | 248.6 M | 261.1 M |
| WST | 12 M | 75.7 M | 76.9 M | 85.2 M | 90 M | 89.9 M | 90.7 M | 96.7 M | 104.4 M | 103.3 M | 109.1 M | 122.3 M | 120.6 M | 137.3 M | 155.4 M | 163.2 M |
| ICUI | 100 K | 18.3 M | 19 M | 19.5 M | 19.4 M | 18.1 M | 19.1 M | 66.6 M | 74.7 M | 85.2 M | 94.8 M | 99.3 M | 258.8 M | 228.8 M | 263.1 M | 276.2 M |
| MMSI | 100 K | 19.2 M | 22.5 M | 32.5 M | 35.9 M | 37.4 M | 43.8 M | 53.6 M | 69.5 M | 104.4 M | 106.8 M | 95.8 M | 92.2 M | 101.3 M | 114.7 M | 120.5 M |
| MBOT | 400 K | 1.2 M | 991.7 K | 1.1 M | 1.3 M | 1.1 M | 10 K | 21 K | 54 K | 84 K | 68 K | 76 K | 102 K | 106 K | 95.4 K | 90.6 K |
| BDX | 59.4 M | 510.9 M | 546 M | 562 M | 891 M | 1.1 B | 1.1 B | 2 B | 2.8 B | 2 B | 2.1 B | 2.1 B | 2.2 B | 2.3 B | 2.6 B | 2.8 B |
| COO | 14.3 M | 24 M | 30.2 M | 35.7 M | 51.5 M | 60.8 M | 68.4 M | 146.7 M | 125.5 M | 319.6 M | 341.1 M | 378.3 M | 367.7 M | 367.7 M | 422.9 M | 444 M |
| HOLX | 100 K | 72 M | 112.6 M | 113.8 M | 491.4 M | 465.4 M | 449.2 M | 480.3 M | 463.1 M | 376 M | 406.9 M | 430.1 M | 323.4 M | 309 M | 355.4 M | 373.1 M |
| RGEN | 500 K | 1.3 B | 3.5 M | 3.1 M | 4 M | 4.6 M | 5.3 M | 10.5 M | 15.8 M | 20.9 M | 27.1 M | 38.4 M | 51 M | 68.1 M | 68.4 M | 44.5 M |
| HAE | 7 M | 50 M | 65.5 M | 81.7 M | 86.1 M | 90 M | 89.7 M | 89.2 M | 109.4 M | 110.3 M | 84.3 M | 97.7 M | 93.3 M | 97.2 M | 111.8 M | 117.4 M |
| NVST | 127.2 M | 127.2 M | 127.2 M | 127.2 M | 127.2 M | 127.2 M | 127.2 M | 121.4 M | 130 M | 168.1 M | 163.1 M | 151.9 M | 162.1 M | 162.6 M | 154.4 M | 163.9 M |
| ANGO | 9.8 M | 13 M | 29.1 M | 25.1 M | 30.5 M | 28.4 M | 24.8 M | 23.2 M | 25.9 M | 23.8 M | 26.3 M | 29.5 M | 33.2 M | 27.7 M | 31.9 M | 18.5 M |
| ATR | 26.2 M | 134.2 M | 137 M | 150 M | 152.2 M | 138.9 M | 154.8 M | 153.1 M | 171.7 M | 220.9 M | 220.3 M | 234.9 M | 233.7 M | 248.6 M | 263.8 M | 136.9 M |
STAAR Surgical and related stocks such as ResMed Inc, West Pharmaceutical, and ICU Medical Depreciation And Amortization description
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.My Equities
My Current Equities and Potential Positions
| STAAR Surgical | STAA |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 17.57
Check out STAAR Surgical Performance and STAAR Surgical Correlation. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
STAAR Surgical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.